Cognition Therapeutics, Inc. (NASDAQ:CGTX) is among the fundamentally strong penny stocks to invest in. H.C. Wainwright has ...

Goldman Sachs ' fondness for technology expands with their latest testing of "Devin," the AI coding agent from Cognition which went viral last year because of its capabilities as well as its ...

Cognition Therapeutics surges 35% after a positive FDA meeting for Alzheimer’s drug zervimesine. Read more here.

The arrival of agentic AI at Goldman Sachs, in which programs don’t just help with tasks but execute complex jobs, signals a ...

If you or a loved one is over the age of 65, and has had serious changes in cognition or memory lately, then it's important ...

Following a Mediterranean diet long-term may have weight loss benefits but it may not be enough to enhance cognitive function ...

McMinn Endowed Research Professor in Science Vladimir Pravosudov has been named the Regents’ Outstanding Researcher in the ...

Thinking’s our whole thing. A company that promises—however jokily—to do your thinking for you is, not even subtly, also ...

Turning a childhood curiosity into cutting-edge research, Richmond explores animal behavior and cognition in natural ...

The AI software engineer making its debut on Wall Street was created by Cognition, a startup founded in 2023 and backed by ...

Cognition Therapeutics shares surged after the clinical-stage company said it completed the end-of-Phase 2 meeting with the Food and Drug Administration for its zervimesine drug. Shares were up 30% at ...

Good physical performance is associated with better cognition in people with relapsing-remitting MS, according to a recent study by the University of Eastern Finland. Good functional capacity was ...